2026 Advanced Chemical & Biotech Patent Institute
May 11 to 12, 2026
Location
San Francisco, CA, USA
Contact
Credits
CLE calculations pending
Registration
The Advanced Chemical & Biotech Patent Institute is an in-depth continuing legal education program tailored specifically for experienced patent practitioners in the chemical and biotech fields. This advanced course offers a comprehensive view from both prosecution and litigation perspectives, covering crucial topics relevant to practice in the U.S. and internationally.
Program Highlights:
- Advanced Patent Prosecution Techniques: Master the nuances of preparing and prosecuting patent applications effectively from experts with 20+ years of experience.
- Navigating Legal Challenges: Explore the complexities of written description from both U.S. and global perspectives and learn strategies to withstand challenges from the PTAB and the courts.
- Optimize Your Patent Practice: Understand and adapt to changes stemming from recent legislative updates and USPTO guidelines.
- Due Diligence in View of Current Case Law: Gain insights into conducting thorough due diligence, considering the latest developments in case law.
- Leveraging AI Tools: Discover how to utilize AI technologies to enhance efficiency and optimize your patent practice.
- Client Counseling and Strategic Decisions: Enhance your ability to counsel clients effectively and make informed strategic portfolio and business decisions.
Don't miss this opportunity to elevate your practice and stay ahead in the dynamic fields of Chemical and Biotech patent law.
Fees:
If you plan on attending the Spring Meeting, there is special pricing for this event. You must register for the Spring Meeting at the same time.
If you only want to attend the 2026 Advanced Chemical Patent Practice Institute, select this event and click "Individual Registration".
_________________________________________________________________________________________________________________________
Thank you to our sponsor!
Please email Lisa Beller if you are interested in sponsoring this event.
News
-
AIPLA Files Amicus Curiae Brief Re Case G 1/25 (Adaptation of the Description)
February 3, 2026
Arlington, VA. January 28, 2026 – The American Intellectual Property Law Association (AIPLA) filed amicus curiae observations in response to the invitation of the European Patent Office (EPO) Enlarged Board of Appeal in Case G 1/25, which addresses whether and to what extent a patent description must be adapted when claims are amended during opposition or opposition-appeal proceedings. -
AIPLA Comments to the USPTO on the Proposed Rulemaking for Required Use by Foreign Applicants and Patent Owners of a Patent Practitioner
January 30, 2026
Arlington, VA. January 28, 2026 - The American Intellectual Property Law Association (AIPLA) submitted comments to the USPTO in response to the NPRM for “Required Use by Foreign Applicants and Patent Owners of a Patent Practitioner.” -
AIPLA Comments to USPTO on PTAB NPRM
December 3, 2025
Arlington, VA. December 2, 2025 - The American Intellectual Property Law Association (AIPLA) submitted comments in response to the USPTO's October 17, 2025, Notice of Proposed Rulemaking on Revisions to the PTAB's Rules of Practice. -
AIPLA Comments to UK IPO on Designs Framework Consultation
December 1, 2025
Arlington, VA. November 25, 2025 - The American Intellectual Property Law Association (AIPLA) submitted comments in response to the UK IPO’s Designs Consultation published in September 2025 (the “Consultation”). -
Letter in Support - S. 1546 - Patent Eligibility Restoration Act
October 8, 2025
Arlington, VA. October 8, 2025 - The American Intellectual Property Law Association (AIPLA) submitted a letter in support for S. 1546, the Patent Eligibility Restoration Act.